Registered entities
Escient Pharmaceuticals, Inc.
Reg. No. 82-2065265United States
Innovation
13 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 249 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 1 |
Investor mix
14 investors on record; lead investors include Sanofi Ventures, Perceptive Advisors, Redmile Group, 5AM Ventures; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 71% |
| Private equity | 2 | 14% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 1 | 7% |